← Every applicant

Glenmark Pharms FDA Approvals

5 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.

Newest first

A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.

Product
PROGESTERONENew drugApr 8, 2026INSERT, VAGINAL
LACOSAMIDENew drugJan 21, 2026SOLUTION, INTRAVENOUS
ERIBULIN MESYLATENew drugAug 5, 2025SOLUTION, INTRAVENOUS
OLOPATADINE HYDROCHLORIDENew drugFeb 28, 2025SOLUTION/DROPS, OPHTHALMIC
ACETYLCYSTEINENew drugFeb 3, 2022INJECTABLE, INTRAVENOUS

Related datasets